RNS Number : 7011R
Chemring Group PLC
10 June 2024
 

FOR IMMEDIATE RELEASE                                                                                                         10 JUNE 2024

 

CHEMRING GROUP PLC ("Chemring", the "Group" or the "Company")

 

LONG-TERM SUPPLY AGREEMENT AND CONTRACT AWARD

 

Chemring is pleased to announce that its Norwegian subsidiary, Chemring Nobel, has signed a 15-year partnering agreement with Northrop Grumman for the supply of HMX energetic material used in its missile programmes. This agreement, which reflects the increasing desire of our customers to move to long-term partnering agreements, builds on the two companies' long-standing relationship and supports Northrop Grumman's efforts to expand its munitions manufacturing production in response to growing customer demand.

 

As part of this agreement, Chemring also received a delivery order from Northrop Grumman, valued at $83m, for the supply of HMX. Deliveries under this order will commence in FY26 and will be made over the following three years, with all work being carried out at Chemring Nobel's facility at Sӕtre, Norway.

 

Michael Ord, Chief Executive of Chemring, commented:

 

"These awards, which illustrate the long-term and valued relationship that we enjoy with Northrop Grumman, support our decision to invest in increasing the capacity of our three energetics businesses over the medium-term, and reinforces Chemring's position as a key supplier to NATO."

 

 

For further information:

Rupert Pittman           Group Director of Corporate Affairs,                  01794 463401

                                      Chemring Group PLC             

 

James McFarlane        MHP Group                                                             07584 142665

Ollie Hoare                                                                                                     07817 458804

           

Cautionary statement

 

This announcement contains forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements. There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are: increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects. Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

Notes to editors

 

·   Chemring is a FTSE250 global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

·   Employing approximately 2,600 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

·   Chemring is organised under two strategic product segments: Sensors & Information and Countermeasures & Energetics

·   Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

·   Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTQKFBQKBKDPAK